AGIO
Agios Pharmaceuticals, Inc.
$27.79
+0.94%
2026-05-08
About Agios Pharmaceuticals, Inc.
Agios Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops medicines in the field of cellular metabolism in the United States. Its lead product includes PYRUKYND (mitapivat), an activator of wild-type and mutant pyruvate kinase (PK), enzymes used for the treatment of hemolytic anemias in adults with PK deficiency. The company's PYRUKYND product is also used for the treatment of sickle cell disease that is in phase 3 clinical trial; for the treatment of PK deficiency in pediatric patients; and AQVESME for the treatment of adult patients with non-transfusion dependent and transfusion-dependent alpha- or beta-thalassemia. In addition, it developed tebapivat, a PK activator for the treatment of lower-risk myelodysplastic syndrome and sickle cell disease; AG-181, a phenylalanine hydroxylase stabilizer for the treatment of phenylketonuria (PKU); and AG-236, an siRNA in-licensed from Alnylam, targeting the transmembrane serine protease 6 (TMPRSS6) gene for the treatment of polycythemia vera. Agios Pharmaceuticals, Inc. was incorporated in 2007 and is headquartered in Cambridge, Massachusetts.
Key Fundamentals
Forward P/E
-6.02
EPS (TTM)
$-7.26
ROE
-32.8%
Revenue Growth (YoY)
137.7%
Profit Margin
0.0%
Debt/Equity
3.22
Price/Book
1.48
Beta
0.58
Market Cap
$1.65B
Avg Volume (10D)
1.2M
Recent Breakout Signals
No recent breakout signals detected for AGIO.
Recent Price Range (60 Days)
60D High
$36.35
60D Low
$24.29
Avg Volume
1.0M
Latest Close
$27.79
Get breakout alerts for AGIO
Sign up for Breakout Scanner to receive daily notifications when AGIO triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Agios Pharmaceuticals, Inc. (AGIO) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors AGIO daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. AGIO operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.